Followers | 514 |
Posts | 38725 |
Boards Moderated | 5 |
Alias Born | 04/26/2012 |
Friday, January 11, 2019 6:35:16 PM
William Stilley, CEO of Adial Pharmaceuticals, said, “We are expanding our activities around AD04 to include opioid use disorder (OUD) and believe this program has significant potential since the physiology and neuro-transmitters involved in opioid addiction are similar to alcohol and could be expected to be modulated by a serotonin-3 receptor antagonist.”
https://ih.advfn.com/stock-market/NASDAQ/adial-pharmaceuticals-inc-ADIL/stock-news/78881798/adial-pharmaceuticals-announces-planned-expansion
Replies:
"ADIL - Adial has previously announced that it
PENNIEStoSTACKS on 12/27/2018 10:52:53 AM
Report TOS
:)
All my posts are my opinion only. Please do your due diligence on all your investments.
Recent ADIL News
- Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 09/19/2024 12:30:00 PM
- Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/04/2024 01:00:00 PM
- Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/14/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:13:57 PM
- Adial Pharmaceuticals Signs Agreement with Boudicca Dx to Advance Regulatory Strategy for Companion Diagnostic Genetic Test for AD04 • GlobeNewswire Inc. • 08/13/2024 01:00:00 PM
- Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 08/07/2024 01:00:00 PM
- Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044 • GlobeNewswire Inc. • 07/31/2024 12:30:00 PM
- Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 07/23/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/20/2024 12:30:00 PM
- Adial Pharmaceuticals Achieves Important Milestone of First Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder • GlobeNewswire Inc. • 06/05/2024 12:30:00 PM
- Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th • GlobeNewswire Inc. • 05/29/2024 12:30:00 PM
- Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/15/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 09:03:18 PM
- Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 04/22/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder • GlobeNewswire Inc. • 04/10/2024 12:30:00 PM
- Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/02/2024 12:30:00 PM
- Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds • GlobeNewswire Inc. • 03/02/2024 12:00:00 AM
- Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/28/2024 02:30:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:22:13 PM
- Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office • GlobeNewswire Inc. • 02/13/2024 02:15:24 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/25/2024 09:30:56 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/25/2024 05:15:07 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:15:23 PM
- Adial Announces Appointment of Tony Goodman as Chief Operating Officer • GlobeNewswire Inc. • 01/18/2024 01:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/16/2024 09:17:10 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM